December 27, 2017
Ongoing monitoring for genetic changes in chronic lymphocytic leukemia (CLL) during targeted treatment may allow clinicians to adjust patients’ treatments as the cancer evolves, according to a study published in Nature Communications led by Weill Cornell Medicine and New York Genome Center scientists. Physicians usually genetically profile a patient’s cancer […]
